Evidence map›Paper›PMID 28620838›Full record

ArticleJournal of molecular neuroscience : MN2017

Modelling FUS Mislocalisation in an In Vitro Model of Innervated Human Muscle.

Sonja Prpar Mihevc, Mojca Pavlin, Simona Darovic, Marko Živin, Matej Podbregar, Boris Rogelj, Tomaz Mars

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. In Vitro Models of Amyotrophic Lateral Sclerosis.Cellular and molecular neurobiology · 2023
    Review
  2. Article
  3. Challenges and Future Prospects on 3DFrontiers in bioengineering and biotechnology · 2018
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sonja Prpar MihevcDepartment of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia.
Mojca PavlinNano and Biotechnological Applications Group, Faculty of Electrical Engineering, University of Ljubljana, Ljubljana, Slovenia.
Simona DarovicDepartment of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia.
Marko ŽivinInstitute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Matej PodbregarInstitute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Boris RogeljDepartment of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia.
Tomaz MarsInstitute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. tomaz.mars@mf.uni-lj.si.ORCID http://orcid.org/0000-0003-0241-4891
University of Ljubljana · SIJožef Stefan Institute · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Degeneration of distal axons and neuromuscular junctions is an early feature in the pathology of amyotrophic lateral sclerosis (ALS), which culminates in motor neuron loss due to axon retraction and muscle atrophy. The complex interactions in the pathogenesis of ALS between motor neurons, muscle cells and accompanying glia require an appropriate experimental model. Here, we have defined a co-culture model based on human myotubes innervated by neurons from embryonic rat spinal cord explants to investigate the pathology and treatment of ALS. This model was first characterised for endogenous expression and distribution of ALS-related proteins TDP-43 and FUS. Then, wild-type FUS and its mutants were introduced into these co-cultures to determine how FUS defects in nuclear transport modulate the pathological conditions. FUS-bearing plasmids were introduced by classical transfection and electroporation, as novel approaches to deliver plasmids into explants, and their cellular distributions were characterised. Endogenous nuclear expression of TDP-43 and FUS was observed in explants and myoblasts/myotubes. After transfection, wild-type FUS was expressed in nuclei of myoblasts, myotubes and explants, although with low transfection rates. Following successful electrotransfection into explants, the localisation of wild-type FUS was nuclear, and it was detected in neurons, astrocytes, Schwann cells and oligodendrocyte precursors, whereas the FUS∆Y, FUSY526A and FUSY526E mutants were cytoplasmic, and the FUSY526F mutant was nuclear and cytoplasmic. This co-culture model is applicable to the study of neuronal and non-neuronal cell contributions to ALS and other neurodegenerative diseases, and it can be used to investigate drug targets amenable to intervention.

Indexed as

Amyotrophic Lateral SclerosisAnimalsCells, CulturedHumansMuscle Fibers, SkeletalNeuronsProtein TransportRatsRats, WistarRNA-Binding Protein FUSSpinal CordFUS protein, humanRNA-Binding Protein FUSAmyotrophic lateral sclerosisCo-cultureElectroporationFUSMuscle cultureSpinal cord

Identifiers

PMID28620838
OpenAlexW2626178103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.